Solventum Corp
SOLV · NYSE · United States · Health Care · HC Equipment & Services
- Coverage
- FY2021–FY2025
- History
- 5 years
- Latest filing
- 10-K · SEC EDGAR
- Reporting
- USD
- Fiscal year end
- December
- Last updated
- Feb 2026
Headline figures
Solventum Corp at a glance
In FY2025, Solventum Corp reported revenue of USD 8,325 mn, EBITDA of USD 1,593 mn, EBITDA margin of 19.1%.
| USD mn | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | 8,254 | 8,325 | |||
| EBITDA | 2,080 | 1,593 | |||
| EBITDA margin | 25.2% | 19.1% | |||
| Free cash flow | 805 | -10 | |||
| ROIC | 11.3% | 10.9% |
The full 5-year history, every line item and each formula are in the platform.
In the platform
- Stat Book — normalized and as-reported IS, BS and CF
- Up to 10 years of annual and quarterly history
- Peer benchmarking and the stock screener
- Corporate risk scorecard
- DCF model from the filed inputs
- Tearsheet and live Excel formulas